Latest News about Psychedelic/Assisted Therapies

Recent news which mentions Psychedelic/Assisted Therapies

< Previous 1 2 3 4 5 6 7 8 9

...

Alternative Treatment For Bipolar II Depression: Psilocybin Safe And Effective, AMA Study Finds

December 06, 2023

NFL's Jon Feliciano Takes His Psychedelics Advocacy To The Field: Chooses MAPS As His "My Cleats, My Cause"

December 05, 2023

Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More

December 05, 2023

Braxia Scientific's Q2 2024: Cash Burn Over But Income Low, What's Next For Psychedelics Company?

December 04, 2023

Super Model Chrissy Teigen Talks About Ketamine Therapy Session, Says She Saw 'Space & Time'

December 04, 2023

Cybin's Novel Psilocybin Topline Data: 79% Remission In Major Depression Symptoms, What's Next?

December 03, 2023

Red Light Holland, With $12M Cash Balance & Revenue Up 33%, Remains 'Confident' In Business Strategy

November 29, 2023

Seelos Therapeutics' $5.55M Public Offering As Stock Drop 35%

November 29, 2023

Defense Dept. Funds Ketamine Study For PTSD Treatment In 600 Service Members & Veterans

November 27, 2023

Global Psychedelics: Norwegian User Trends & Finnish Interdisciplinary Conference

November 26, 2023

Global Psychedelics: Australia's Prescription Guidelines, New Zealand's Meth Addiction Treatment

November 24, 2023

Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More

November 24, 2023

Clearmind Medicine's Reverse Stock Split And Nasdaq Delisting Notice

November 21, 2023

Three Johns Hopkins Psychedelics Professors Call The Shots On Live Q&A: Knowns, Unknowns, Regulations & Hopes

November 20, 2023

UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center

November 15, 2023

GH Research: Steady Expenses And $229M Cash Position For 2026 Runway

November 14, 2023

Atai Life Sciences' Q3 Earnings: Near $20M Burned QoQ, Says Funding 'Sufficient' To Streamline 2026

November 14, 2023

Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More

November 12, 2023

Veterans Day: Can Psychedelic Treatment Help Stem PTSD-Related Suicides Among Veterans?

November 11, 2023

Cybin Launches Five-Day Units Offering For Up To $64M, Suspends Prior LPC Funding Deal

November 10, 2023

Worldwide Psychedelics Events: Miami, Croatia, D.C., France, UK, NY, Oregon, Arizona & SXSW

November 09, 2023

Canada To Australia: New MDMA & Psilocybin Shipment On Its Way For Legal Therapeutic Market

November 08, 2023

Psychedelics Reform In California, Wisconsin, Illinois, Massachusetts & Pennsylvania

November 05, 2023

MindMed Q3 2023: Financials, Business Funded By 2026 If LSD Pipeline Milestones Achieved

November 03, 2023

Single Dose Of Cybin's Psilocybin Shows Compelling Patient Outcomes, Phase 2 Results Find

November 01, 2023

Ketamine Company Acquisition Alert: Beckley Waves Adds Nue Life To Its Portfolio

October 26, 2023

EXCLUSIVE: Becoming Compliant In Today's Legal Psychedelics Markets With Allay Consulting

October 26, 2023

Cybin Officially Owns Small Pharma: Plans For New 'International Leader' In Psychedelic Therapeutics

October 23, 2023

Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted

October 22, 2023

Psychedelics Decriminalization In California: Eureka City Council Latest To Pass Resolution

October 22, 2023

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.